These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 7835164)

  • 41. Identification of DNA--cisplatin adducts in a blind trial of in situ scanning tunneling microscopy.
    Jeffrey AM; Jing TW; DeRose JA; Vaught A; Rekesh D; Lu FX; Lindsay SM
    Nucleic Acids Res; 1993 Dec; 21(25):5896-900. PubMed ID: 8290350
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Optimization of immunofluorescence methods by quantitative image analysis.
    Mosedale DE; Metcalfe JC; Grainger DJ
    J Histochem Cytochem; 1996 Sep; 44(9):1043-50. PubMed ID: 8773570
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Automated measurement of estrogen receptor in breast cancer: a comparison of fluorescent and chromogenic methods of measurement.
    Zarrella ER; Coulter M; Welsh AW; Carvajal DE; Schalper KA; Harigopal M; Rimm DL; Neumeister VM
    Lab Invest; 2016 Sep; 96(9):1016-25. PubMed ID: 27348626
    [TBL] [Abstract][Full Text] [Related]  

  • 44. JPEG2000 for automated quantification of immunohistochemically stained cell nuclei: a comparative study with standard JPEG format.
    Lejeune M; López C; Bosch R; Korzyńska A; Salvadó MT; García-Rojo M; Neuman U; Witkowski Ł; Baucells J; Jaén J
    Virchows Arch; 2011 Feb; 458(2):237-45. PubMed ID: 21085985
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quantification of diverse subcellular immunohistochemical markers with clinicobiological relevancies: validation of a new computer-assisted image analysis procedure.
    Lejeune M; Jaén J; Pons L; López C; Salvadó MT; Bosch R; García M; Escrivà P; Baucells J; Cugat X; Alvaro T
    J Anat; 2008 Jun; 212(6):868-78. PubMed ID: 18510512
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Automated quantification of nuclear immunohistochemical markers with different complexity.
    López C; Lejeune M; Salvadó MT; Escrivà P; Bosch R; Pons LE; Alvaro T; Roig J; Cugat X; Baucells J; Jaén J
    Histochem Cell Biol; 2008 Mar; 129(3):379-87. PubMed ID: 18172664
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of amifostine on cisplatin induced DNA adduct formation and toxicity in malignant glioma and normal tissues in rat.
    Bergström P; Johnsson A; Bergenheim T; Henriksson R
    J Neurooncol; 1999 Mar; 42(1):13-21. PubMed ID: 10360475
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetics and tissue distribution of cisplatin in nude mice: platinum levels and cisplatin-DNA adducts.
    Johnsson A; Olsson C; Nygren O; Nilsson M; Seiving B; Cavallin-Stahl E
    Cancer Chemother Pharmacol; 1995; 37(1-2):23-31. PubMed ID: 7497593
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A topographic study on the distribution of cisplatin in xenografted tumors on nude mice.
    Johnsson A; Cavallin-Stahl E
    Anticancer Drugs; 1996 Jan; 7(1):70-7. PubMed ID: 8742101
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of GADD153 in tumor cells and stromal cells from xenografted tumors in nude mice treated with cisplatin: correlations with cisplatin-DNA adducts.
    Johnsson A; Strand C; Los G
    Cancer Chemother Pharmacol; 1999; 43(4):348-52. PubMed ID: 10071988
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Induction of tumor-specific antitumor immunity after chemotherapy with cisplatin in mice bearing MOPC-104E plasmacytoma by modulation of MHC expression on tumor surface.
    Nio Y; Hirahara N; Minari Y; Iguchi C; Yamasawa K; Toga T; Tamura K
    Anticancer Res; 2000; 20(5A):3293-9. PubMed ID: 11062756
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of a method for quantitative immunohistochemical analysis of cisplatin-DNA adducts in tissues from nude mice.
    Johnsson A; Olsson C; Anderson H; Cavallin-Ståhl E
    Cytometry; 1994 Oct; 17(2):142-50. PubMed ID: 7835164
    [TBL] [Abstract][Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.